Company news

Haemonetics Corporation news in 2026

Haemonetics Corporation's news releases, calls and decks from 2026, newest first.

View company

Q2 2027 Haemonetics Corporation Earnings Release

November 5, 2026

2nd Quarter FY27 Earnings Release

November 5, 2026

Haemonetics Corporation Announces Second Quarter Fiscal 2027 Financial Results Available on Investor Relations Website

November 5, 2026

Haemonetics Announces FDA Approval of PerQseal® Elite Vascular Closure System

October 19, 2026

Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2027 Results: November 5, 2026

September 30, 2026

Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website

August 6, 2026

New Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths

August 3, 2026

Martin Madaus Elected to Haemonetics Board of Directors

July 28, 2026

Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2027 Results: August 6, 2026

July 8, 2026

Haemonetics Updates Financial Reporting Segments

June 5, 2026

Haemonetics to Present at Goldman Sachs 47th Annual Global Healthcare Conference

June 2, 2026

Haemonetics Corporation Announces Fourth Quarter Fiscal 2026 Financial Results Available on Investor Relations Website

May 7, 2026

Haemonetics to Present at Bank of America 2026 Healthcare Conference

May 5, 2026

New Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures

April 24, 2026

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026

April 1, 2026

Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System

March 30, 2026

Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology

February 23, 2026

Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference

February 20, 2026

Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website

February 5, 2026

Vivasure Medical Announces Acquisition by Haemonetics Corporation

January 9, 2026

Haemonetics Acquires Vivasure Medical Limited

January 9, 2026

Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2026 Results: February 5, 2026

January 7, 2026

Haemonetics to Present at 44th Annual J.P. Morgan Healthcare Conference

January 2, 2026

Calls in 2026

Decks in 2026